TTNP

Titan Pharmaceuticals
TTNP

Delisted

TTNP was delisted on the 1st of October, 2025.

Back to rankings

20 hedge funds and large institutions have $158K invested in Titan Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
20
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$47.8K
2
+$3.5K
3
+$454
4
Raymond James Financial
Raymond James Financial
Florida
+$4

Top Sellers

1
-$20
2
-$8
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$50.7K
Renaissance Technologies
2
Renaissance Technologies
New York
$47.8K
MG
3
Marex Group
$44.8K
UBS Group
4
UBS Group
Switzerland
$14.4K
CA
5
CoreCap Advisors
Michigan
$370
Bank of America
6
Bank of America
North Carolina
$75
Group One Trading
7
Group One Trading
Illinois
$50
Osaic Holdings
8
Osaic Holdings
Arizona
$40
BlackRock
9
BlackRock
New York
$25
Morgan Stanley
10
Morgan Stanley
New York
$8
GWSA
11
Global Wealth Strategies & Associates
Colorado
$8
RA
12
Ransom Advisory
Rhode Island
$4
Wells Fargo
13
Wells Fargo
California
$4
CIA
14
Cape Investment Advisory
Georgia
$4
CSC
15
Caldwell Sutter Capital
California
$4
DJSG
16
D.J. St. Germain
Massachusetts
$4
WIM
17
Westside Investment Management
California
$4
SS
18
SBI Securities
Japan
$4
NRG
19
Nemes Rush Group
Michigan
$4
Raymond James Financial
20
Raymond James Financial
Florida
$4